Sensitivity of the Elecsys Nucleocapsid Assay for the Detection of Preceding SARS-CoV-2 Infections
暂无分享,去创建一个
B. Grunau | S. O’Brien | S. Drews | P. Lavoie | D. Goldfarb | V. Barakauskas | M. Asamoah-Boaheng | Sadaf Sediqi | Janessa Tom
[1] P. Demers,et al. A Prospective Observational Cohort Comparison of SARS-CoV-2 Seroprevalence Between Paramedics and Matched Blood Donors in Canada During the COVID-19 Pandemic , 2022, Annals of Emergency Medicine.
[2] P. Demers,et al. Evaluation of the Performance of a Multiplexed Serological Assay in the Detection of SARS-CoV-2 Infections in a Predominantly Vaccinated Population , 2022, Microbiology spectrum.
[3] H. Woo,et al. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies , 2022, Frontiers in Immunology.
[4] S. Ghedira,et al. Comparative study of six SARS-CoV-2 serology assays: Diagnostic performance and antibody dynamics in a cohort of hospitalized patients for moderate to critical COVID-19 , 2022, International journal of immunopathology and pharmacology.
[5] C. Bergin,et al. Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals , 2021, Journal of Infection.
[6] R. D. Nerenz,et al. A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays , 2021, Clinical Biochemistry.
[7] J. Dunne,et al. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays , 2021, medRxiv.
[8] P. Glasziou,et al. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. , 2020, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada.
[9] P. Bieniasz,et al. Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients , 2020, The Journal of Infectious Diseases.
[10] G. Rodger,et al. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison , 2020, The Lancet Infectious Diseases.
[11] Aashish Manglik,et al. Test performance evaluation of SARS-CoV-2 serological assays , 2020, Nature Biotechnology.